Tenaya Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference Life Science Investing
Spero Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update on August 12, 2026 Life Science Investing
Precigen Reports Second Quarter 2026 Financial Results Highlighted by Accelerating PAPZIMEOS Revenue Growth Life Science Investing
Taysha Gene Therapies to Release Second Quarter 2026 Financial Results and Host Conference Call and Webcast on August 11 Life Science Investing
Immix Biopharma to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference Biotech Investing
RenovoRx to Highlight TAMP Platform at JonesTrading Virtual Key Opinion Leader Webinar on the Evolving Pancreatic Cancer Landscape, August 13th Life Science Investing
Alzamend Neuro Announces Initial Closing of Securities Purchase Agreement with Ault Lending Life Science Investing
Nuvectis Pharma Reports Second Quarter 2026 Financial Results and Business Highlights Life Science Investing
Palvella Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update Life Science Investing
